The biological cost of mutational antibiotic resistance: any practical conclusions?
about
Experimental evolution in biofilm populations.The fitness costs of antibiotic resistance mutationsGain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulenceMortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studiesA reservoir of drug-resistant pathogenic bacteria in asymptomatic hostsInterplay in the selection of fluoroquinolone resistance and bacterial fitnessPervasive sign epistasis between conjugative plasmids and drug-resistance chromosomal mutationsCompensatory evolution of pbp mutations restores the fitness cost imposed by β-lactam resistance in Streptococcus pneumoniaeDynamics of resistance development to imatinib under increasing selection pressure: a combination of mathematical models and in vitro dataComparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective studyIntra-subtype variation in enteroadhesion accounts for differences in epithelial barrier disruption and is associated with metronidazole resistance in Blastocystis subtype-7The Role of Adherence and Retreatment in De Novo Emergence of MDR-TBThe SOS response controls integron recombination.Origins and evolution of antibiotic resistanceEscherichia coli Population Structure and Antibiotic Resistance at a Buffalo/Cattle Interface in Southern Africa.Evolution of restraint in a structured rock-paper-scissors community.On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient.Antibiotic innovation may contribute to slowing the dissemination of multiresistant Streptococcus pneumoniae: the example of ketolides.Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genesAssessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections.Clinical isolates of Mycobacterium tuberculosis in four European hospitals are uniformly susceptible to benzothiazinonesCapacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: Implications for the conjugate vaccineChallenges of antibacterial discoveryInformed switching strongly decreases the prevalence of antibiotic resistance in hospital wards.Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrataAmplification of the gene for isoleucyl-tRNA synthetase facilitates adaptation to the fitness cost of mupirocin resistance in Salmonella enterica.Antibiotic dose impact on resistance selection in the community: a mathematical model of beta-lactams and Streptococcus pneumoniae dynamicsThe evolution of plasmid-carried antibiotic resistance.Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosisProspective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty.Whole genome analysis of linezolid resistance in Streptococcus pneumoniae reveals resistance and compensatory mutations.Costs and benefits of mutational robustness in RNA virusesNo apparent costs for facultative antibiotic production by the soil bacterium Pseudomonas fluorescens Pf0-1.Plasmid-encoded tetracycline efflux pump protein alters bacterial stress responses and ecological fitness of Acinetobacter oleivorans.Fitness of Escherichia coli strains carrying expressed and partially silent IncN and IncP1 plasmids.Compensatory mutations restore fitness during the evolution of dihydrofolate reductaseCTX-M beta-lactamase production and virulence of Escherichia coli K1Emerging resistance in Neisseria meningitidis and Neisseria gonorrhoeae.Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomesNovel classes of antibiotics or more of the same?
P2860
Q26768691-AE5FDCE0-F3F9-4055-9A41-6967D428869AQ26825334-C558B6FA-9BC3-45EF-9D46-91D776E8F324Q27318203-9D77EEF7-5ABC-4F20-A912-93E85A5FEB79Q28068844-7C8F8832-7D3F-420F-A6D0-51FFB4BF1BD2Q28474039-8F61BFD1-FED2-46E3-8F03-8AF570548ED2Q28475870-D0E3C5BB-F608-4765-B2B3-94952B5DB50CQ28476356-8C66F2D2-3CCA-4BB7-A47B-8B9D43219875Q28477183-F122FA02-8951-45EF-98A3-0D7522452315Q28478542-8669B27C-629C-41A7-A272-CA0892FC7B5EQ28479276-908E50E6-1C90-4A7F-AD9B-9FD7B3FD5611Q28539056-2AB94190-9962-4AE9-AFD6-77CAACA490FAQ28550707-709E0C2A-BD78-4D5C-96FD-ACF9DADAF0C6Q29346620-C3EA24C2-DD09-4B8A-BAFE-B23B0DFB58F2Q29617791-B19C0A5D-3788-4F63-BA06-BA9799F44963Q30382202-684CD8D8-2F54-40DC-8C4D-E6D578FAE26DQ30502276-7A1E44A0-AA4B-4027-A634-81CCBAB69FACQ30519515-AEE8CE81-809F-4FDC-A2A6-925BF6C64BA9Q33332126-7AA8D0F0-303F-422A-A203-12BD0BC5432BQ33559090-09EBAC47-70D1-47EC-A2DF-515B5BD419CCQ33564290-E4DB8555-F5CF-4959-AA01-4CD9E574E7D8Q33768910-528CC763-2BDE-45CA-ACB9-3127B41F01F6Q33777082-F4FDE95C-0864-46AB-AE8B-4A78B0D747D2Q33793074-53D624D9-BDC7-4EB3-8414-C1FA924F6CB7Q33842121-71A6FA5C-0021-4FA5-9D2D-892A615FC8BFQ33847058-78BBB626-3FFC-4E03-A4B4-B569A54104DEQ33853188-0471EB41-DA19-4818-951A-EC07B0953314Q33876556-17948929-D67C-4E38-9CD5-E1D3E579C048Q33905942-E3C51212-5F25-4D66-A853-3D7C49E5D135Q33926262-0754BF6A-9BE0-4EA9-B0C7-C9EA5D0CED3EQ34047599-0A328322-5123-441F-B23B-61291FB97BC0Q34049640-5B10E729-7B0A-4269-8E09-24CC8AE3A0FDQ34079587-F6FF369A-6FED-4D95-AAC6-6AC4A11A775BQ34081478-9FB22560-748B-4355-8E93-99C7B7BFCCE3Q34207402-AB41226D-067A-4DB7-8C56-00C3741BEA9AQ34219902-4EC5710A-303B-4763-9862-C37F06C1CC5DQ34310777-06127547-CE84-4411-B546-577139EA40ACQ34603776-7B74C496-AC5E-4A89-98BB-8C377501AB70Q34627129-5690A175-25D6-4977-8637-1E1087B6DCBCQ34766191-1F8AE4FE-2710-4863-9ADE-69FF4FC0352AQ34903245-9391ED5E-4282-40D5-B05C-D65CAD9705FA
P2860
The biological cost of mutational antibiotic resistance: any practical conclusions?
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The biological cost of mutational antibiotic resistance: any practical conclusions?
@ast
The biological cost of mutational antibiotic resistance: any practical conclusions?
@en
The biological cost of mutational antibiotic resistance: any practical conclusions?
@nl
type
label
The biological cost of mutational antibiotic resistance: any practical conclusions?
@ast
The biological cost of mutational antibiotic resistance: any practical conclusions?
@en
The biological cost of mutational antibiotic resistance: any practical conclusions?
@nl
prefLabel
The biological cost of mutational antibiotic resistance: any practical conclusions?
@ast
The biological cost of mutational antibiotic resistance: any practical conclusions?
@en
The biological cost of mutational antibiotic resistance: any practical conclusions?
@nl
P1476
The biological cost of mutational antibiotic resistance: any practical conclusions?
@en
P2093
Dan I Andersson
P304
P356
10.1016/J.MIB.2006.07.002
P577
2006-08-04T00:00:00Z